Objectives:

1. Discuss concepts in ICP reduction with blood pressure, autoregulation, and hypertonic therapy.

2. Compare and contrast differences, advantages, and disadvantages of various hypertonic therapy.

3. Review 2 cases of TBI patients with refractory elevations in ICP, requiring pentobarbital coma.

4. Understand the protocol and consequences of pentobarbital on ICP control.

5. Review literature on effectiveness of pentobarbital on ICP control, brain tension oxygen, and outcomes in TBI.

Session date: 
Wednesday, May 29, 2019 - 7:30am to 8:30am
Speaker Name: 
Jared Davis, MD
Location: 
UCM
5841 S. Maryland Avenue
Room H-103
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.